Michigan Initial Experience Using Tigertriever for Thrombectomy
Recruiting
Observational Study
Blood Clot
Thrombectomy
Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Henry Ford Health System · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication.
2. Tigertriever was used as the first line treatment in the target vessel.
3. A signed informed consent.
4. Age ≥ 18.
Exclusion Criteria:
-1. Evidence of a…
Contacts